New products swell the top line and eat away at the bottom line for Janssen-Cilag
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4294756.ece/ALTERNATES/schema-16_9/OK_Johnson___Johnso_317224e.jpg)
The Johnson & Johnson-owned Danish company Janssen-Cilag emerged from 2011 with a moderate growth, as turnover rose 0.7 % from DKK 279 to 281 million in 2011.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.